# Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

> **NCT06881927** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 212 (estimated)

## Conditions studied

- Sepsis and Septic Shock
- Acute Respiratory Failure
- Kidney Transplant Recipients
- Immunosuppressive Agents

## Interventions

- **DRUG:** Hydrocortisone Hemisuccinate: 200 mg per day.
- **OTHER:** reduction of the level of immunosuppression

## Key facts

- **NCT ID:** NCT06881927
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2029-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06881927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06881927, "Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06881927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*